Montréal, Canada

Karl A Hansford

USPTO Granted Patents = 1 



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karl A. Hansford: Innovator in Interleukin-1 Receptor Antagonists

Introduction

Karl A. Hansford is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents targeting inflammatory diseases. His work has led to the creation of a patent that addresses critical health issues related to interleukin-1 receptor activity.

Latest Patents

Hansford holds a patent for "Interleukin-1 receptor antagonists, compositions, and methods of treatment." This invention focuses on peptides designed to inhibit the biological activity of the IL-1R type 1 receptor. The patent outlines compositions that include IL-1R antagonists, which are beneficial in treating IL-1 related diseases such as arthritis, rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease. The invention also describes an isolated compound with IL-1R antagonist activity, which includes a peptide with the amino acid sequence RYTPELX and its derivatives.

Career Highlights

Throughout his career, Hansford has worked with various organizations, including Valorisation-Recherche Société En Commandite and Valorisation Hsj, Société En Commandite. His expertise in biochemistry and innovative approaches to treatment have positioned him as a key figure in his field.

Collaborations

Hansford has collaborated with notable professionals such as Sylvain Chemtob and Christiane Quiniou. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Karl A. Hansford's contributions to the field of biochemistry, particularly through his patent on interleukin-1 receptor antagonists, highlight his role as an innovator in medical treatments for inflammatory diseases. His work continues to impact the scientific community and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…